381 related articles for article (PubMed ID: 33662286)
1. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis.
Ward ZJ; Scott AM; Hricak H; Atun R
Lancet Oncol; 2021 Mar; 22(3):341-350. PubMed ID: 33662286
[TBL] [Abstract][Full Text] [Related]
2. The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.
Ward ZJ; Atun R; Hricak H; Asante K; McGinty G; Sutton EJ; Norton L; Scott AM; Shulman LN
Lancet Oncol; 2021 Sep; 22(9):1301-1311. PubMed ID: 34416159
[TBL] [Abstract][Full Text] [Related]
3. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
Ward ZJ; Scott AM; Hricak H; Abdel-Wahab M; Paez D; Lette MM; Vargas HA; Kingham TP; Atun R
Lancet Oncol; 2020 Aug; 21(8):1077-1088. PubMed ID: 32758462
[TBL] [Abstract][Full Text] [Related]
4. The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.
Ward ZJ; Grover S; Scott AM; Woo S; Salama DH; Jones EC; El-Diasty T; Pieters BR; Trimble EL; Vargas HA; Hricak H; Atun R
Lancet Oncol; 2020 Aug; 21(8):1089-1098. PubMed ID: 32758463
[TBL] [Abstract][Full Text] [Related]
5. Expanding global access to radiotherapy.
Atun R; Jaffray DA; Barton MB; Bray F; Baumann M; Vikram B; Hanna TP; Knaul FM; Lievens Y; Lui TY; Milosevic M; O'Sullivan B; Rodin DL; Rosenblatt E; Van Dyk J; Yap ML; Zubizarreta E; Gospodarowicz M
Lancet Oncol; 2015 Sep; 16(10):1153-86. PubMed ID: 26419354
[TBL] [Abstract][Full Text] [Related]
6. Medical imaging and nuclear medicine: a Lancet Oncology Commission.
Hricak H; Abdel-Wahab M; Atun R; Lette MM; Paez D; Brink JA; Donoso-Bach L; Frija G; Hierath M; Holmberg O; Khong PL; Lewis JS; McGinty G; Oyen WJG; Shulman LN; Ward ZJ; Scott AM
Lancet Oncol; 2021 Apr; 22(4):e136-e172. PubMed ID: 33676609
[TBL] [Abstract][Full Text] [Related]
7. Global childhood cancer survival estimates and priority-setting: a simulation-based analysis.
Ward ZJ; Yeh JM; Bhakta N; Frazier AL; Girardi F; Atun R
Lancet Oncol; 2019 Jul; 20(7):972-983. PubMed ID: 31129029
[TBL] [Abstract][Full Text] [Related]
8. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
Rodin D; Burger EA; Atun R; Barton M; Gospodarowicz M; Grover S; Hanna TP; Jaffray DA; Knaul FM; Lievens Y; Zubizarreta E; Milosevic M
Lancet Oncol; 2019 Jul; 20(7):915-923. PubMed ID: 31151906
[TBL] [Abstract][Full Text] [Related]
9. Guide posts for investment in primary health care and projected resource needs in 67 low-income and middle-income countries: a modelling study.
Stenberg K; Hanssen O; Bertram M; Brindley C; Meshreky A; Barkley S; Tan-Torres Edejer T
Lancet Glob Health; 2019 Nov; 7(11):e1500-e1510. PubMed ID: 31564629
[TBL] [Abstract][Full Text] [Related]
10. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
[TBL] [Abstract][Full Text] [Related]
11. Sustainable care for children with cancer: a Lancet Oncology Commission.
Atun R; Bhakta N; Denburg A; Frazier AL; Friedrich P; Gupta S; Lam CG; Ward ZJ; Yeh JM; Allemani C; Coleman MP; Di Carlo V; Loucaides E; Fitchett E; Girardi F; Horton SE; Bray F; Steliarova-Foucher E; Sullivan R; Aitken JF; Banavali S; Binagwaho A; Alcasabas P; Antillon F; Arora RS; Barr RD; Bouffet E; Challinor J; Fuentes-Alabi S; Gross T; Hagander L; Hoffman RI; Herrera C; Kutluk T; Marcus KJ; Moreira C; Pritchard-Jones K; Ramirez O; Renner L; Robison LL; Shalkow J; Sung L; Yeoh A; Rodriguez-Galindo C
Lancet Oncol; 2020 Apr; 21(4):e185-e224. PubMed ID: 32240612
[TBL] [Abstract][Full Text] [Related]
12. Global return on investment and cost-effectiveness of WHO's HEAR interventions for hearing loss: a modelling study.
Tordrup D; Smith R; Kamenov K; Bertram MY; Green N; Chadha S;
Lancet Glob Health; 2022 Jan; 10(1):e52-e62. PubMed ID: 34919856
[TBL] [Abstract][Full Text] [Related]
13. Timing and cost of scaling up surgical services in low-income and middle-income countries from 2012 to 2030: a modelling study.
Verguet S; Alkire BC; Bickler SW; Lauer JA; Uribe-Leitz T; Molina G; Weiser TG; Yamey G; Shrime MG
Lancet Glob Health; 2015 Apr; 3 Suppl 2():S28-37. PubMed ID: 25926318
[TBL] [Abstract][Full Text] [Related]
14. Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries.
Schäferhoff M; Zimmerman A; Diab MM; Mao W; Chowdhary V; Gill D; Karanja R; Madikizela M; Ogbuoji O; Yamey G
Lancet Glob Health; 2022 Jul; 10(7):e1045-e1052. PubMed ID: 35714631
[TBL] [Abstract][Full Text] [Related]
15. Estimates and Projections of the Global Economic Cost of 29 Cancers in 204 Countries and Territories From 2020 to 2050.
Chen S; Cao Z; Prettner K; Kuhn M; Yang J; Jiao L; Wang Z; Li W; Geldsetzer P; Bärnighausen T; Bloom DE; Wang C
JAMA Oncol; 2023 Apr; 9(4):465-472. PubMed ID: 36821107
[TBL] [Abstract][Full Text] [Related]
16. Economic costs of childhood stunting to the private sector in low- and middle-income countries.
Akseer N; Tasic H; Nnachebe Onah M; Wigle J; Rajakumar R; Sanchez-Hernandez D; Akuoku J; Black RE; Horta BL; Nwuneli N; Shine R; Wazny K; Japra N; Shekar M; Hoddinott J
EClinicalMedicine; 2022 Mar; 45():101320. PubMed ID: 35308896
[TBL] [Abstract][Full Text] [Related]
17. Resource needs for adolescent friendly health services: estimates for 74 low- and middle-income countries.
Deogan C; Ferguson J; Stenberg K
PLoS One; 2012; 7(12):e51420. PubMed ID: 23300548
[TBL] [Abstract][Full Text] [Related]
18. Achieving a "Grand Convergence" in Global Health: Modeling the Technical Inputs, Costs, and Impacts from 2016 to 2030.
Boyle CF; Levin C; Hatefi A; Madriz S; Santos N
PLoS One; 2015; 10(10):e0140092. PubMed ID: 26452263
[TBL] [Abstract][Full Text] [Related]
19. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026.
Global Burden of Disease 2021 Health Financing Collaborator Network
Lancet Glob Health; 2023 Mar; 11(3):e385-e413. PubMed ID: 36706770
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
